Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Patent Bar > Chapter 2400 > Flashcards

Chapter 2400 Flashcards

You may prefer our related Brainscape-certified flashcards:
MBE flashcards
1
Q

2401

A

Introduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2402

A

The Deposit Rules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2403

A

Deposit of Biological Material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2403.01

A

Material Capable of Self- Replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2403.02

A

Plant Material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2404

A

Need or Opportunity to Make a Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2404.01

A

Biological Material That Is Known and Readily Available to the Public

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2404.02

A

Biological Material That Can Be Made or Isolated Without Undue Experimentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2404.03

A

Reference to a Deposit in the Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2405

A

Acceptable Depository

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2406

A

Time of Making an Original Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2406.01

A

Description in Application Specification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2406.02

A

Deposit After Filing Date - Corroboration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2406.03

A

Possible Loss of U.S. Filing Date in Other Countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2407

A

Replacement or Supplement of Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2407.01

A

In a Pending Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2407.02

A

After a Patent Has Issued

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2407.03

A

Failure to Replace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2407.04

A

Treatment of Replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

2407.05

A

Exemption From Replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

2407.06

A

Replacement May Not Be Recognized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

2408

A

Term of Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

2409

A

Viability of Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

2410

A

Furnishing of Samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

2410.01

A

Conditions of Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

2410.02

A

Certification of Statement of Availability of Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2411

A

Examination Procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

2411.01

A

Rejections Based on Deposit Issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

2411.02

A

Replies to Rejections Based on Deposit Issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

2411.03

A

Application in Condition for Allowance Except for Deposit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

2411.05

A

Content of Application with Respect to Deposited Material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

2412

A

The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

2412.01

A

Overview of the Sequence Rules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

2412.02

A

Definition of “Sequence Listing XML”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

2412.02(a)

A

“Enumeration of its residues”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

2412.03

A

Nucleotides and Amino Acids Included and Excluded From a “Sequence Listing XML”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

2412.03(a)

A

“Specifically Defined”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

2412.03(b)

A

“Amino Acid”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

2412.03(c)

A

“Modified Amino Acid”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

2412.03(d)

A

“Nucleotide”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

2412.03(e)

A

“Modified Nucleotide”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

2412.04

A

Use of Sequence Identifiers to Denote Sequences Disclosed in the Description or Claims

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

2412.05

A

Representation and Symbols for Nucleotide and/or Amino Acid Sequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

2412.05(a)

A

Use of Sequentially Numbered Sequence Identifiers in the “Sequence Listing XML”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

2412.05(b)

A

Representation and Symbols of Nucleotide Sequence Data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

2412.05(c)

A

Representation and Inclusion of Variants

47
Q

2412.05(d)

A

Representation and Symbols of Amino Acid Sequence Data

48
Q

2412.05(e)

A

Presentation of Special Situations

49
Q

2412.06

A

The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures

50
Q

2412.07

A

Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences

51
Q

2413

A

Content of “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File

52
Q

2413.01

A

Parts of the “Sequence Listing XML”

53
Q

2413.01(a)

A

The “Sequence Listing XML” is a Single File Encoded Using Unicode UTF-8

54
Q

2413.01(b)

A

The “Sequence Listing XML” Must Be Valid According To the DTD

55
Q

2413.01(c)

A

The “Sequence Listing XML” Must Contain an XML Declaration

56
Q

2413.01(d)

A

The “Sequence Listing XML” Must Contain a DOCTYPE Declaration

57
Q

2413.01(e)

A

The “Sequence Listing XML” Must Contain a Root Element

58
Q

2413.01(f)

A

The “Sequence Listing XML” Must Contain a General Information Part

59
Q

2413.01(g)

A

The “Sequence Listing XML” Must Contain a Sequence Data Part

60
Q

2413.01(h)

A

Language Dependent Free Text Qualifiers in the English Language

61
Q

2413.01(i)

A

Title Element in “Sequence Listing XML”

62
Q

2413.02

A

Form and Format of the XML file containing the “Sequence Listing XML”

63
Q

2413.03

A

How to Submit the “Sequence Listing XML”

64
Q

2413.04

A

Requirements Regarding Incorporation By Reference of the “Sequence Listing XML”

65
Q

2413.05

A

Presumptions Regarding Compliance

66
Q

2414

A

Notification of a Failure to Comply with Sequence Listing Requirements and Amendments Relating to “Sequence Listing XML” Files Under 37 CFR 1.835

67
Q

2414.01

A

Issuance of a Notice Relating to the Requirements For Patent Applications Containing Nucleotide and/or Amino Acid Sequence Disclosures

68
Q

2414.02

A

Amendment to Add an Initial “Sequence Listing XML” under 37 CFR 1.835(a)

69
Q

2414.03

A

Amendment Adding to, Deleting from, or Replacing Sequence Information in a “Sequence Listing XML” under 37 CFR 1.835(b)

70
Q

2414.04

A

Translation of “Sequence Listing XML” is Not an Amended “Sequence Listing XML” under 37 CFR 1.835(b)

71
Q

2414.05

A

Notifications for Failure to Submit a “Sequence Listing XML” in an International Application under the PCT to be Searched by the United States International Searching Authority or Examined by International Preliminary Examination Authority

72
Q

2414.06

A

Compliance with “Sequence Listing XML” for Any Amendment to a Patent

73
Q

2415

A

Applicability date of “Sequence Listing XML” Requirements to Applications Based on Filing Date of Application and Procedures for Failure to Submit Correct Format of Sequence Listing

74
Q

2415.01

A

Determining when a Sequence Listing in XML format must be submitted

75
Q

2415.02

A

Provisional Applications Containing Disclosures of Nucleotides and/or Amino Acids, Compliance with 37 CFR 1.831-1.834

76
Q

2415.03

A

Improper Submissions of “Sequence Listing” under 1.821(c)(1)-(3) When a “Sequence Listing XML” was Required

77
Q

2416

A

Form Paragraphs

78
Q

2418

A

WIPO Sequence Tool

79
Q

2419

A

Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”

80
Q

2419.01

A

Patent Grants and Patent Application Publications Containing a Non-Lengthy “Sequence Listing XML”

81
Q

2419.02

A

Patent Grants and Patent Application Publications Containing a Lengthy “Sequence Listing XML”

82
Q

2419.03

A

Patent Grants and Patent Application Publications Containing a “Sequence Listing XML” of 1GB or Larger

83
Q

2420

A

The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules

84
Q

2421

A

Overview of the Sequence Rules under WIPO ST.25

85
Q

2421.01

A

Definition of “Sequence Listing” and Computer Readable Form (CRF)

86
Q

2421.02

A

Summary of the Requirements of the Sequence Rules

87
Q

2421.03

A

Notification of a Failure to Comply

88
Q

2422

A

Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25

89
Q

2422.01

A

Nucleotide and/or Amino Acids Disclosures Requiring a “Sequence Listing”

90
Q

2422.02

A

The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures

91
Q

2422.03

A

Sequence Listing Submission

92
Q

2422.03(a)

A

“Sequence Listing” Submitted as ASCII Plain Text Files

93
Q

2422.04

A

The Requirement for a Computer Readable Copy of the “Sequence Listing”

94
Q

2422.06

A

Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form

95
Q

2422.07

A

Requirements for Compliance and Consequences of Non-Compliance

96
Q

2422.08

A

Presumptions Regarding Compliance

97
Q

2423

A

Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data for WIPO ST.25

98
Q

2423.01

A

Format and Symbols To Be Used in a “Sequence Listing”

99
Q

2423.02

A

Depiction of Coding Regions

100
Q

2423.03

A

Presentation and Numbering of Sequences

101
Q

2424

A

Requirements for Content of a “Sequence Listing” Part of the Specification under WIPO ST.25.

102
Q

2424.01

A

Informational Requirements for the “Sequence Listing”

103
Q

2424.02

A

“Sequence Listing” Numeric Identifiers

104
Q

2424.03

A

Additional Miscellaneous Requirements

105
Q

2425

A

Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25

106
Q

2426

A

Amendments to Add or Replace a “Sequence Listing” and CRF Copy Thereof Subject to WIPO ST. 25

107
Q

2427

A

Form Paragraphs for Applications Subject to WIPO ST.25

108
Q

2428

A

Sample Statements under WIPO ST.25

109
Q

2429

A

Helpful Hints for Sequence Rules Compliance under WIPO ST.25

110
Q

2430

A

PatentIn Information

111
Q

2431

A

Sample “Sequence Listing” under WIPO ST.25

112
Q

2433

A

Box Sequence; Hand Delivery of a “Sequence Listing” and Computer Readable Forms

113
Q

2434

A

Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences

114
Q

2435

A

2435-Publishing of Patents and Patent Application Publications with a Lengthy “Sequence Listing”

Patent Bar (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions